The company is a high-tech service enterprise with third-party medical testing and pathological diagnosis services as the core. Through continuous accumulation of core resource advantages such as “big platform, big network, big service, large sample and big data”, the company is committed to providing leading medical diagnostic information integration services for medical institutions at all levels across the country. The company's main business is in key disease fields such as clinical specialties, hematologic diseases, neurological and clinical immune diseases, and solid tumors. Physico-chemical mass spectrometry tests, genomic tests, pathological diagnosis, biochemiluminescence tests, immunological tests, other comprehensive tests, etc. Corporate honors: It won the “2018 Responsible Brand Award” at the 8th China Charity Festival; the “2018 Social Responsibility · Health Public Welfare Poverty Alleviation Contribution Award” was awarded in the “2018 New Express - New Backbone · New Motivation” event; and the “China County Hospital's Most Influential Discipline Co-construction Award” was awarded at the 2019 China Health County Conference. The company was honored with honorary titles such as “Guangdong Guangcai Business Contribution Award” and “Guangzhou Five-Star Charity Unit”.
No Data